← Back to Search

"Liberal O2" for Respiratory Depression

N/A
Waitlist Available
Led By Anthony Doufas, MD, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up forty minutes of monitoring for each treatment arm
Awards & highlights

Study Summary

This trial will explore how oxygen can help people recover from anesthesia more quickly. #medicine

Eligible Conditions
  • Respiratory Depression
  • Respiratory Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~forty minutes of monitoring for each treatment arm
This trial's timeline: 3 weeks for screening, Varies for treatment, and forty minutes of monitoring for each treatment arm for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Respiratory disturbance index (RDI)
Transcutaneous carbon dioxide pressure (TcPCO2)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: "Liberal O2"Experimental Treatment1 Intervention
During the second treatment session, which will last for 40 minutes, O2 supplementation will be titrated to an SpO2 > 96%.
Group II: "Conservative O2"Active Control1 Intervention
During the first treatment session, which will last for 40 minutes, O2 supplementation will be titrated to an SpO2 between 90% and 94%.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,408 Previous Clinical Trials
17,343,197 Total Patients Enrolled
1 Trials studying Respiratory Depression
80 Patients Enrolled for Respiratory Depression
Anthony Doufas, MD, PhDPrincipal InvestigatorProfessor, Department of Anesthesiology, Stanford University Medical School
2 Previous Clinical Trials
68 Total Patients Enrolled

Media Library

"Liberal O2" Clinical Trial Eligibility Overview. Trial Name: NCT05922020 — N/A
Respiratory Depression Research Study Groups: "Conservative O2", "Liberal O2"
Respiratory Depression Clinical Trial 2023: "Liberal O2" Highlights & Side Effects. Trial Name: NCT05922020 — N/A
"Liberal O2" 2023 Treatment Timeline for Medical Study. Trial Name: NCT05922020 — N/A
~6 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top